www.msn.com

www.msn.com
Share

www.msn.com

 •  February 16

A potentially groundbreaking new treatment for herpes could be nigh, according to a recent study conducted at the University of Illinois at Chicago. The study, which is detailed in the journal Science Translational Medicine, reports that researchers have discovered that a drug molecule known as BX795 is effective in temporarily clearing the herpes...

www.msn.com

 •  February 13

By Philip Stevens THE PATENT-BASED system of drug development will came under further pressure from key countries aiming to increase access to medicines at the executive board meeting World Health Organization in March. Critics of the system want reform, arguing it makes drugs too expensive and fails to provide cures for those in need who may be...

www.msn.com

 •  February 12

President Donald Trump finally explained how he plans to fulfill his promise of lowering prescription drug prices -- at least in part. On Monday, his administration released its 2019 budget blueprint, which proposed changes to payment policies in Medicare and Medicaid and fast-tracking the development of generic drugs as ways to help accomplish...

www.msn.com

 •  February 12

We're sorry, but your browser does not support this video. Please install Adobe Flash version 10 or later. Duration: 00:38 1 day ago Newsy 0:44 Newsy 0:56 Newsy 0:57 Newsy 0:54 Newsy 0:33 Newsy 0:46 Newsy 0:38 Newsy 0:54 Newsy 0:42 Newsy 4:44 Newsy 6:13 Newsy 0:45 Newsy 0:47

www.msn.com

 •  February 10

The American government is cracking down on kratom, a plant native to southeast Asia that many in the US are turning to for relief from pain, depression, and symptoms of opioid withdrawal. The herb, technically legal but unregulated in the US, often comes in the form of a powder, which can be mixed into teas, or as part of a dietary supplement...

www.msn.com

 •  February 1

There are many reform proposals, including some from free-market think tanks. [Question] I keep hearing that many promising new drugs for cancer and other diseases are not legally available in this country because of excessively long and expensive approval processes at the U.S. Food and Drug Administration. What can be done to speed things up...

www.msn.com

 •  January 21

Slide 1 of 10:

If you’re frustratedthat your health insurance premiums are heading higher, you’re not alone.Health insurance costs are increasing far faster than inflation and millions ofAmericans are getting hit with double-digit increases. What’s to blame for theclimbing costs? Here are nine reasons we’re paying more money than ever for...

www.msn.com

 •  January 18

PTC Therapeutics Inc. this month increased the list price of its muscular-dystrophy treatment by about 9%, to more than $65,000 annually for a common dosage. The price increase again puts a spotlight on Emflaza, a decades-old steroidal drug that many U.S. patients had been paying $1,200 or less annually to import from Europe before the Food and...

www.msn.com

 •  January 9

WASHINGTON — Empowering Medicare to negotiate drug prices could leave patients with reduced access to medications, President Donald Trump’s pick for health secretary warned Tuesday. Alex Azar, a former pharmaceutical and government executive, acknowledged to the Senate Finance Committee that drug prices are too high and said he’d work to lower them...

www.msn.com

 •  January 3

Video by CNBC A first-of-its kind genetic treatment for blindness will cost $850,000, less than the $1 million price tag that had been expected but still among the most expensive medicines in the world. Spark Therapeutics said Wednesday it decided on the lower price for Luxturna (Lux-turn-a) after hearing concerns from health insurers about their...